Completed NA INTERVENTIONAL 3-arm NCT01207856

Randomised Controlled Clinical Trial of Cognitive Rehabilitation in Multiple Sclerosis (REACTIV)

Randomised Controlled Clinical Trial of Cognitive Rehabilitation in Multiple Sclerosis and Assessment by Neuroimaging

Sponsor: ARSEP foundation

Conditions Cognitive Rehabilitation Multiple Sclerosis

Interventions no intervention non specific cognitive rehabilitation specific cognitive rehabilitation

Updated 5 times since 2017 Last updated: Feb 8, 2016 Started: May 31, 2011 Primary completion: Jul 31, 2015 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01207856, this NA trial focuses on Cognitive Rehabilitation and Multiple Sclerosis and remains completed. Sponsored by ARSEP foundation, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ARSEP foundation
Merck Serono International SA
University Hospital, Bordeaux

Data source: University Hospital, Bordeaux

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bordeaux, France